EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY 4.0

Prevalence and impact of sarcopenia in individuals with heart failure with reduced ejection fraction (the SARC-HF study): A prospective observational study protocol

Pablo Marino Corrêa Nascimento iD, Luiz Fernando Rodrigues Junior iD, Mauro Felippe Felix Mediano, Valéria Gonçalves da Silva iD, Bernardo Rangel Tura, Fabio César Sousa Nogueira iD, Gilberto Domont, Adriana Bastos Carvalho, Antônio Carlos Campos de Carvalho, Taís Hanae Kasai-Brunswick, Claudio Tinoco Mesquita, Humberto Villacorta Junior iD und 1 weitere

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0300918 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift PLOS ONE, 2024. Verfasst von Pablo Marino Corrêa Nascimento und 12 weiteren Autor:innen. Beteiligte Einrichtung: National Institute of Cardiology, Rio de Janeiro, Brazil. Hauptthemen laut MEDLINE: Sarcopenia, Heart Failure. Die Arbeit nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sarcopenia, a clinical syndrome primarily associated with reduced muscle mass in the elderly, has a negative impact on quality of life and survival. It can occur secondarily to other diseases such as heart failure (HF), a complex clinical syndrome with high morbidity and mortality. The simultaneous occurrence of these two conditions can worsen the prognosis of their carriers, especially in the most severe cases of HF, as in patients with reduced left ventricular ejection fraction (LVEF). However, due to the heterogeneous diagnostic criteria for sarcopenia, estimates of its prevalence present a wide variation, leading to new criteria having been recently proposed for its diagnosis, emphasizing muscle strength and function rather than skeletal muscle mass. The primary objective of this study is to evaluate the prevalence of sarcopenia and/or dynapenia in individuals with HF with reduced LVEF according to the most recent criteria, and compare the gene and protein expression of those patients with and without sarcopenia. The secondary objectives are to evaluate the association of sarcopenia and/or dynapenia with the risk of clinical events and death, quality of life, cardiorespiratory capacity, ventilatory efficiency, and respiratory muscle strength. The participants will answer questionnaires to evaluate sarcopenia and quality of life, and will undergo the following tests: handgrip strength, gait speed, dual-energy X-ray absorptiometry, respiratory muscle strength, cardiopulmonary exercise, as well as genomic and proteomic analysis, and dosage of N-terminal pro-B-type natriuretic peptide and growth differentiation factor-15. An association between sarcopenia and/or dynapenia with unfavorable clinical evolution is expected to be found, in addition to reduced quality of life, cardiorespiratory capacity, ventilatory efficiency, and respiratory muscle strength.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcopeniaHeart FailureHumansAgedStroke VolumeHand StrengthPrevalenceQuality of LifeProteomicsVentricular Function, LeftMuscle StrengthMuscle, SkeletalObservational Studies as Topic

Autor:innen und Institutionen

  • National Institute of Cardiology, Rio de Janeiro, Brazil.
  • Fluminense Federal University, Niterói, Brazil.
  • Federal University of the State of Rio de Janeiro, Rio de Janeiro, Brazil.
  • Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
  • Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.

ORCID-Profile: Pablo Marino Corrêa Nascimento, Luiz Fernando Rodrigues Junior, Valéria Gonçalves da Silva, Fabio César Sousa Nogueira, Humberto Villacorta Junior, Helena Cramer Veiga Rey

Förderung

  • Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro

Zitieren

APA

Nascimento, P. M. C., Rodrigues Junior, L. F., Felix Mediano, M. F., Gonçalves da Silva, V., Tura, B. R., Nogueira, F. C. S., Domont, G., Carvalho, A. B., de Carvalho, A. C. C., Kasai-Brunswick, T. H., Mesquita, C. T., Junior, H. V., & Rey, H. C. V. (2024). Prevalence and impact of sarcopenia in individuals with heart failure with reduced ejection fraction (the SARC-HF study): A prospective observational study protocol. PLOS ONE. https://doi.org/10.1371/journal.pone.0300918

Vancouver

Nascimento PMC, Rodrigues Junior LF, Felix Mediano MF, Gonçalves da Silva V, Tura BR, Nogueira FCS, et al. Prevalence and impact of sarcopenia in individuals with heart failure with reduced ejection fraction (the SARC-HF study): A prospective observational study protocol. PLOS ONE. 2024. doi:10.1371/journal.pone.0300918

BibTeX
@article{Nascimento2024,
  author = {Nascimento, Pablo Marino Corrêa and Rodrigues Junior, Luiz Fernando and Felix Mediano, Mauro Felippe and Gonçalves da Silva, Valéria and Tura, Bernardo Rangel and Nogueira, Fabio César Sousa and Domont, Gilberto and Carvalho, Adriana Bastos and de Carvalho, Antônio Carlos Campos and Kasai-Brunswick, Taís Hanae and Mesquita, Claudio Tinoco and Junior, Humberto Villacorta and Rey, Helena Cramer Veiga},
  title = {Prevalence and impact of sarcopenia in individuals with heart failure with reduced ejection fraction (the SARC-HF study): A prospective observational study protocol},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0300918}
}
Kostenlos starten →